452 related articles for article (PubMed ID: 26935961)
1. CATheter Infections in CHildren (CATCH): a randomised controlled trial and economic evaluation comparing impregnated and standard central venous catheters in children.
Harron K; Mok Q; Dwan K; Ridyard CH; Moitt T; Millar M; Ramnarayan P; Tibby SM; Muller-Pebody B; Hughes DA; Gamble C; Gilbert RE
Health Technol Assess; 2016 Mar; 20(18):vii-xxviii, 1-219. PubMed ID: 26935961
[TBL] [Abstract][Full Text] [Related]
2. Generalisability and Cost-Impact of Antibiotic-Impregnated Central Venous Catheters for Reducing Risk of Bloodstream Infection in Paediatric Intensive Care Units in England.
Harron K; Mok Q; Hughes D; Muller-Pebody B; Parslow R; Ramnarayan P; Gilbert R
PLoS One; 2016; 11(3):e0151348. PubMed ID: 26999045
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial-impregnated central venous catheters for preventing neonatal bloodstream infection: the PREVAIL RCT.
Gilbert R; Brown M; Faria R; Fraser C; Donohue C; Rainford N; Grosso A; Sinha AK; Dorling J; Gray J; Muller-Pebody B; Harron K; Moitt T; McGuire W; Bojke L; Gamble C; Oddie SJ
Health Technol Assess; 2020 Nov; 24(57):1-190. PubMed ID: 33174528
[TBL] [Abstract][Full Text] [Related]
4. Impregnated central venous catheters for prevention of bloodstream infection in children (the CATCH trial): a randomised controlled trial.
Gilbert RE; Mok Q; Dwan K; Harron K; Moitt T; Millar M; Ramnarayan P; Tibby SM; Hughes D; Gamble C;
Lancet; 2016 Apr; 387(10029):1732-42. PubMed ID: 26946925
[TBL] [Abstract][Full Text] [Related]
5. Cost-Effectiveness of Pediatric Central Venous Catheters in the UK: A Secondary Publication from the CATCH Clinical Trial.
Ridyard CH; Plumpton CO; Gilbert RE; Hughes DA
Front Pharmacol; 2017; 8():644. PubMed ID: 28974929
[No Abstract] [Full Text] [Related]
6. Silver-impregnated, antibiotic-impregnated or non-impregnated ventriculoperitoneal shunts to prevent shunt infection: the BASICS three-arm RCT.
Mallucci CL; Jenkinson MD; Conroy EJ; Hartley JC; Brown M; Moitt T; Dalton J; Kearns T; Griffiths MJ; Culeddu G; Solomon T; Hughes D; Gamble C;
Health Technol Assess; 2020 Mar; 24(17):1-114. PubMed ID: 32238262
[TBL] [Abstract][Full Text] [Related]
7. Antimicrobial-impregnated central venous catheters for prevention of neonatal bloodstream infection (PREVAIL): an open-label, parallel-group, pragmatic, randomised controlled trial.
Gilbert R; Brown M; Rainford N; Donohue C; Fraser C; Sinha A; Dorling J; Gray J; McGuire W; Gamble C; Oddie SJ;
Lancet Child Adolesc Health; 2019 Jun; 3(6):381-390. PubMed ID: 31040096
[TBL] [Abstract][Full Text] [Related]
8. Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults.
Lai NM; Chaiyakunapruk N; Lai NA; O'Riordan E; Pau WS; Saint S
Cochrane Database Syst Rev; 2016 Mar; 3(3):CD007878. PubMed ID: 26982376
[TBL] [Abstract][Full Text] [Related]
9. A clinical and economic evaluation of Control of Hyperglycaemia in Paediatric intensive care (CHiP): a randomised controlled trial.
Macrae D; Grieve R; Allen E; Sadique Z; Betts H; Morris K; Pappachan VJ; Parslow R; Tasker RC; Baines P; Broadhead M; Duthie ML; Fortune PM; Inwald D; McMaster P; Peters MJ; Schindler M; Guerriero C; Piercy D; Slavik Z; Snowdon C; Van Dyck L; Elbourne D
Health Technol Assess; 2014 Apr; 18(26):1-210. PubMed ID: 24780450
[TBL] [Abstract][Full Text] [Related]
10. Prophylactic antibiotics for preventing gram-positive infections associated with long-term central venous catheters in adults and children receiving treatment for cancer.
van den Bosch CH; van Woensel J; van de Wetering MD
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD003295. PubMed ID: 34617602
[TBL] [Abstract][Full Text] [Related]
11. Types of urethral catheter for reducing symptomatic urinary tract infections in hospitalised adults requiring short-term catheterisation: multicentre randomised controlled trial and economic evaluation of antimicrobial- and antiseptic-impregnated urethral catheters (the CATHETER trial).
Pickard R; Lam T; Maclennan G; Starr K; Kilonzo M; McPherson G; Gillies K; McDonald A; Walton K; Buckley B; Glazener C; Boachie C; Burr J; Norrie J; Vale L; Grant A; N'dow J
Health Technol Assess; 2012 Nov; 16(47):1-197. PubMed ID: 23199586
[TBL] [Abstract][Full Text] [Related]
12. Dressings and securement devices for central venous catheters (CVC).
Ullman AJ; Cooke ML; Mitchell M; Lin F; New K; Long DA; Mihala G; Rickard CM
Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD010367. PubMed ID: 26358142
[TBL] [Abstract][Full Text] [Related]
13. Effect of impregnated central venous catheters on thrombosis in paediatric intensive care: Post-hoc analyses of the CATCH trial.
Wu Y; Fraser C; Gilbert R; Mok Q
PLoS One; 2019; 14(3):e0214607. PubMed ID: 30921401
[TBL] [Abstract][Full Text] [Related]
14. Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults.
Lai NM; Chaiyakunapruk N; Lai NA; O'Riordan E; Pau WS; Saint S
Cochrane Database Syst Rev; 2013 Jun; (6):CD007878. PubMed ID: 23740696
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of Minocycline and Rifampin vs Chlorhexidine and Silver Sulfadiazine-Impregnated Central Venous Catheters in Preventing Central Line-Associated Bloodstream Infection in a High-Volume Academic Intensive Care Unit: A Before and after Trial.
Bonne S; Mazuski JE; Sona C; Schallom M; Boyle W; Buchman TG; Bochicchio GV; Coopersmith CM; Schuerer DJ
J Am Coll Surg; 2015 Sep; 221(3):739-47. PubMed ID: 26199017
[TBL] [Abstract][Full Text] [Related]
16. Effect of nurse staffing and antimicrobial-impregnated central venous catheters on the risk for bloodstream infections in intensive care units.
Alonso-Echanove J; Edwards JR; Richards MJ; Brennan P; Venezia RA; Keen J; Ashline V; Kirkland K; Chou E; Hupert M; Veeder AV; Speas J; Kaye J; Sharma K; Martin A; Moroz VD; Gaynes RP
Infect Control Hosp Epidemiol; 2003 Dec; 24(12):916-25. PubMed ID: 14700407
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic antibiotics for preventing Gram positive infections associated with long-term central venous catheters in oncology patients.
van de Wetering MD; van Woensel JB; Lawrie TA
Cochrane Database Syst Rev; 2013 Nov; 2013(11):CD003295. PubMed ID: 24277633
[TBL] [Abstract][Full Text] [Related]
18. Accuracy of bacterial DNA testing for central venous catheter-associated bloodstream infection in children with cancer.
Millar M; Zhou W; Skinner R; Pizer B; Hennessy E; Wilks M; Gilbert RE
Health Technol Assess; 2011 Feb; 15(7):1-114. PubMed ID: 21294989
[TBL] [Abstract][Full Text] [Related]
19. Consistency between guidelines and reported practice for reducing the risk of catheter-related infection in British paediatric intensive care units.
Harron K; Ramachandra G; Mok Q; Gilbert R;
Intensive Care Med; 2011 Oct; 37(10):1641-7. PubMed ID: 21877212
[TBL] [Abstract][Full Text] [Related]
20. The Age of BLood Evaluation (ABLE) randomised controlled trial: description of the UK-funded arm of the international trial, the UK cost-utility analysis and secondary analyses exploring factors associated with health-related quality of life and health-care costs during the 12-month follow-up.
Walsh TS; Stanworth S; Boyd J; Hope D; Hemmatapour S; Burrows H; Campbell H; Pizzo E; Swart N; Morris S
Health Technol Assess; 2017 Oct; 21(62):1-118. PubMed ID: 29067906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
